simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 57;5^{th}-Individual ID 57;5^{th}-Individual ID 57;5^{th}-Individual ID 57;5^{th}-Individual ID 57;;;95^{th}-Individual ID 15;95^{th}-Individual ID 15;95^{th}-Individual ID 15;95^{th}-Individual ID 15;95^{th}-Individual ID 15
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.246416963322097;0.937833652409924;-0.173621501132445;-0.430350174063888;0.902216638605823;;;-0.387024139627935;0.58588903965672;0.0505648214333043;-0.187087254618627;3.44532580334506
;-0.25531286668844;0.91287684517946;-0.177333684797874;-0.44944020216758;0.882547717326868;;;-32.8877336502759;-31.8774838960441;-32.4515991672301;-32.6964077774393;-28.9990274470618
;-0.237521059955754;0.962790459640388;-0.169909317467017;-0.411260145960197;0.921885559884777;;;32.11368537102;33.0492619753576;32.5527288100968;32.322233268202;35.8896790537519
;0.999614103916683;0.999790282621577;0.999864608257331;0.999417474162396;0.999859240612049;;;0.000478501692691036;0.00109841658606691;8.17089760130063e-06;0.00011179566906705;0.0366738590497857
;3.21769373702691e-06;1.28904423261099e-06;6.68643723259326e-07;5.96812027453035e-06;7.08799265559695e-07;;;0.972150511769691;0.957809552360163;0.996360477478524;0.986537847185761;0.757667955038146
